GWAS study of cT1 (LiverMultiScan) in 14,440 UK Biobank participants identified SLC39A as a genetic variant associated with fibro-inflammatory liver disease. Findings highlight SLC39A8 as a potential drug target and reinforce cT1 as a genetics-informed biomarker.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?